Articles

Retirement Weekly: Is the future more uncertain now than ever before?

The future has always been uncertain—and always will be

The Ratings Game: 1.7 million Americans cut the cord last quarter as traditional TV continues to erode

Television viewers continued to cut the cord in droves during the latest quarter as the value proposition of traditional TV dwindled further.

Retirement Weekly: Retirement can disrupt your sleep. How to sleep healthy and avoid the ‘forbidden zone.’

After you retire, your sleep patterns can change. Make sure they change for the better, not for the worse.

Retirement Weekly: Why do people use trusts for estate planning?

Taxes in trusts are much higher than for individuals. What's the advantage?

: How to juice a bet on Nvidia’s stock

Also: market predictions, recession stock picks and the case against buybacks.

Retirement Weekly: News and analysis for those planning for or living in retirement

Retirement news and analysis

: Private companies like Virgin Galactic could deliver science boost, space researcher says

Companies like Virgin Galactic could boost space research, says Moran Bercovici, a professor at the Technion – Israel Institute of Technology

: Jerome Powell says it ‘takes time’ for slowdown in rents to show up in the Fed’s inflation gauge

Federal Reserve Chair Jerome Powell on Friday said that the central bank is aware that rent growth is slowing down across the nation.

The Ratings Game: Affirm’s stock rockets toward best day in 15 months but remains a polarizing play

Affirm continues to draw mixed reactions as its stock explodes higher Friday in the wake of earnings.

: Heineken is the latest Western corporate giant to exit Russia

Beer giant Heineken is the latest major Western company to exit Russia.

: United Auto Workers members vote to strike

The UAW says 97% of the Big Three automobile workers authorize a strike if no deal is reached by the contract's expiration date.

: As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list 

Government negotiations with drugmakers are set to launch amid a growing number of legal challenges.
1 1,424 1,425 1,426 1,427 1,428 1,707